Back to the full story5 sources · Moderna, Merck cancer vaccine shows promise in late-stage trial; Moderna stock soars 90%◆ Timeline
Moderna, Merck cancer vaccine shows promise in late-stage trial; Moderna stock soars 90%
6 reports in the order each was filed. Tap any entry to open that report at its source.
- 01STATAug 19, 10:45 AMSTAT+: Moderna and Merck say mRNA cancer vaccine succeeded in late-stage melanoma trial
- 02STATAug 19, 10:49 AMModerna and Merck say mRNA cancer vaccine succeeded in late-stage melanoma trial
- 03QuartzAug 19, 11:40 AMModerna and Merck's personalized skin cancer vaccine cleared its first large-scale trial
- 04Yahoo FinanceAug 19, 12:28 PMStock Market Today: Dow Rises Ahead Of Fed Minutes; Moderna Soars On Cancer Drug News (Live Coverage)
- 05MarketWatchAug 19, 12:40 PMModerna’s stock doubles on promising cancer-vaccine results
- 06CNBCAug 19, 12:54 PMModerna, Merck cancer vaccine shows promise in late-stage trial; Moderna stock soars 90%